Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis

Arthritis and Rheumatism

Volumn 43, Issue 9, 2000, Pages 2056-2063

  De Bandt, Michel ^a   Grossin, Maggy ^a   Weber, Anne Joëlle ^a   Chopin, Martine ^b   Elbim, Carole ^a   Pla, Marika ^b   Gougerot Pocidalo, Marie Anne ^a   Gaudry, Murielle ^a  

^a BICHAT HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DESTRUCTION; CLINICAL FEATURE; DRUG EFFECT; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE;

ANGIOGENESIS INHIBITORS; ANIMALS; ARTHRITIS, RHEUMATOID; BONE RESORPTION; CYCLOHEXANES; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; LYMPHOKINES; MALE; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; SESQUITERPENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033711671     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200009)43:9<2056::AID-ANR17>3.0.CO;2-2     Document Type: Article

References (26)

1. Angiogenesis and arthritis
2. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis
3. Angiogenesis: Implications for rheumatoid arthritis
4. Intracellular pool of vascular endothelial growth factor in human neutrophils
5. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation in human synovial fluids and rheumatoid synovial tissue
6. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
7. Vascular endothelial growth factor: A cytokine modulating endothelial functions in rheumatoid arthritis
8. Hypoxia augments cytokine (transforming growth factor β and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts
9. Halting angiogenesis suppresses carcinoma cell invasion
10. Angiogenesis inhibition suppresses collagen arthritis
11. Decreased angiogenesis and arthritic disease in rabbits treated with αvβ3 antagonist
12. Organ specific disease provoked by systemic autoimmunity
13. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme
14. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer
15. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cysplatin
16. AGM-1470 (TNP-470) a potent angiogenesis inhibitor, prevent the entry of normal but not transformed endothelial cells into G1 phase of the cell cycle
17. TNP-470: Mechanisms of action and early clinical development
18. A new model of experimental prosthetic joint infection due to methicillin-resistant Staphylococcus aureus: A microbiologic, histopathologic, and magnetic resonance imaging characterization
19. Angiogenesis: A critical process in the pathogenesis of RA. A role for VEGF?
20. The biology of vascular endothelial growth factor
21. Hypoxic reperfusion injury in the inflamed human joint
22. Hypoxia-induced paracrine regulation of vascular endothelial growth factor
23. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor 0-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470)
24. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470)
25. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma
26. Angiogenesis as a possible elusive triggering factor in rheumatoid arthritis